List Biological Laboratories Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • List Biological Laboratories's estimated annual revenue is currently $11.2M per year.(i)
  • List Biological Laboratories's estimated revenue per employee is $155,000

Employee Data

  • List Biological Laboratories has 72 Employees.(i)
  • List Biological Laboratories grew their employee count by 3% last year.

List Biological Laboratories's People

NameTitleEmail/Phone
1
Chief Financial OfficerReveal Email/Phone
2
VPReveal Email/Phone
3
VP Quality & ComplianceReveal Email/Phone
4
Director, Research and DevelopmentReveal Email/Phone
5
Production Director, Manufacturing & Process DevelopmentReveal Email/Phone
6
Director Quality AssuranceReveal Email/Phone
7
Director Sales and Business DevelopmentReveal Email/Phone
8
Sr. Director, FermentationReveal Email/Phone
9
Account ManagerReveal Email/Phone
10
Process Development ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is List Biological Laboratories?

List Labs specializes in the production of native toxins, recombinant proteins, bacterial fermentation, assay development, contract manufacturing, and biotherapeutics. List Labs produces C. difficile toxin A and toxin B, shiga toxins, cholera toxin, anthrax toxins (PA, LF, and EF), pertussis toxin, diphtheria toxin, CRM197, tetanus toxin, staphylococcal enterotoxin B, botulinum toxins as well as several types of lipopolysaccharides (LPS) or endotoxin for purchase by the research community.

keywords:N/A

N/A

Total Funding

72

Number of Employees

$11.2M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.4M72-8%N/A
#2
$12M749%N/A
#3
$16M766%N/A
#4
$20.8M7735%N/A
#5
$22.3M773%N/A